|
Market Cap (1-Jul) $205,017,904 (417th) |
Close (30-Jun) $1.23 |
Volume (30-Jun) 249,053 |
Shortsold (19-Jun) 40,298 (0.02%) (504th) |
|
52w High $1.97 |
52w Low $0.92 |
P/E - |
EPS -0.05 |
RAC released this announcement to the ASX on 10 May 2021, 13:54. The announcement is not marked as price sensitive, and is 15 page(s) in length and 160.06kb in size.
You can view all announcements from RAC and see how they appear on a price chart on the announcements page.
At the date of this announcement, RAC was 0.018% short sold according to ASIC data. It was ranked the 548th most shorted stock on the ASX. It is now ranked as the 504th most shorted stock on the ASX with 0.023% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from RAC | |
|---|---|
| Notification of cessation of securities - RAC | 29 June 2023, 9:54 |
| Proposed issue of securities - RAC | 29 June 2023, 9:52 |
| Initial Director's Interest Notice | 29 June 2023, 9:46 |
| Appendix 2A | 10 May 2021, 13:54 |
| Bisantrene Preclinical Drug Study Published | 10 May 2021, 10:24 |
| Bonus Issue of Options - Letter to Ineligible Shareholders | 7 May 2021, 16:36 |
| Bonus Issue of Options - Letter to Eligible Shareholders | 7 May 2021, 16:36 |
You must be logged in to post a reply.
Race Oncology 